isoxazolidin
analogu
homonucleo
ide
synthes
nucleobasederiv
nitron
uracil
thymin
adenin
employ
cycloaddit
allyl
alcohol
well
alkenylphosphon
allyl
allyloxymethyland
vinyloxymethyland
vinylphosphon
besid
reaction
vinylphosphon
addit
proceed
regioselect
produc
mixtur
major
ci
minor
tran
isoxazolidin
de
vinylphosphon
isoxazolidin
addit
produc
vicin
coupl
shield
effect
noe
correl
employ
configur
assign
well
conform
analysi
find
prefer
conform
sever
isoxazolidin
observ
anomer
effect
pseudoaxi
orient
phosphonylmethoxi
group
obtain
vinyloxymethylphosphon
none
test
compound
endow
vitro
antivir
activ
varieti
dna
rna
virus
subtox
concentr
mm
exhibit
antiprolif
activ
toward
cem
hela
cell
ic
mm
signific
number
antivir
anticanc
drug
classifi
close
structur
analogu
nucleosid
nucleotid
search
new
compound
result
obtain
mani
activ
molecul
show
differ
level
similar
natur
nucleosid
modif
nucleosid
scaffold
practic
unlimit
sinc
sugar
nucleobas
unit
could
alter
also
addit
linker
within
structur
nucleosid
incorpor
list
commonli
use
ribofuranosid
replac
includ
dideoxyfuranos
cyclopentan
cyclopenten
isoxazolidin
ring
also
acycl
entiti
idea
incorpor
isoxazolidin
ring
nucleosid
framework
sugar
replac
first
propos
tronchet
explor
provid
sever
biolog
activ
compound
fig
fluorouracilcontain
isoxazolidin
found
induc
apoptosi
lymphoid
monocytoid
cell
time
show
low
cytotox
antivir
nucleotid
also
discov
among
phosphonyl
isoxazolidin
well
among
analogu
linker
nucleotid
found
potent
inhibitor
revers
transcriptas
differ
retrovirus
truncat
analogu
appear
even
potent
exhibit
inhibitori
activ
concentr
nanomolar
rang
high
cytotox
toward
sever
cancer
cell
line
observ
isoxazolidin
nucleosid
gener
formula
hand
worth
mention
biolog
activ
compound
contain
isoxazolidin
ring
restrict
anticanc
antivir
properti
sinc
found
also
poss
antimicrobi
antifung
antiinflammatori
antioxid
insecticid
activ
among
other
structur
modif
nucleosid
may
also
influenc
stereoelectron
effect
contribut
anomer
effect
thu
control
conform
behavior
sugar
ring
affect
biolog
properti
nucleosid
exemplifi
replac
ring
oxygen
atom
carbon
atom
lead
format
carbanucleosid
modif
result
greater
metabol
stabil
nucleosid
analogu
lack
natur
nglycosid
bond
similar
increas
stabil
achiev
homonucleosid
form
insert
methylen
group
nucleobas
sugar
sugar
mimet
illustr
homoadenosin
moreov
biolog
activ
homonucleosid
also
influenc
greater
conform
flexibl
slightli
improv
lipophil
among
homonucleosid
contain
fivememb
ring
ribofuranosid
mimic
sever
compound
show
pronounc
biolog
activ
identifi
fig
case
compound
retain
hydroxymethyl
group
allow
sequenti
phosphoryl
activ
triphosph
metabolit
furthermor
homonucleotid
contain
nonhydrolyz
pec
bond
also
synthes
obtain
analogu
could
phosphoryl
activ
form
therebi
omit
first
less
effect
monophosphoryl
step
exemplifi
compound
fig
recent
report
synthesi
isoxazolidinecontain
analogu
homonucleosid
nucleobas
b
isoxazolidin
ring
synthet
approach
reli
applic
cycloaddit
allyl
alcohol
nucleobasederiv
nitron
paper
full
account
alreadi
commun
preliminari
studi
given
reactiv
nitron
select
alkenylphosphon
lead
new
seri
nucleotid
analogu
describ
togeth
result
antivir
cytostat
activ
scheme
synthesi
nucleobasederiv
nitron
recent
describ
cycloaddit
nitron
allyl
alcohol
carri
c
mw
irradi
scheme
tabl
reaction
regiospecif
produc
cistran
mixtur
diastereoisomer
cycloadduct
moder
good
diastereoselect
de
cistran
ratio
isoxazolidin
calcul
h
nmr
spectra
reaction
mixtur
comparison
integr
diagnost
reson
h
proton
isoxazolidin
ring
well
signal
respect
proton
nucleobas
moieti
rel
configur
homonucleosid
alreadi
establish
base
noe
experi
assign
extend
well
pair
diastereoisom
due
almost
ident
spectral
pattern
h
proton
also
diastereotop
proton
h
ceb
h
ceoh
moieti
respect
h
nmr
spectra
continu
studi
reactiv
nitron
allylphosphon
allyloxymethylphosphon
vinyloxymethylphosphon
vinylphosphon
select
dipolarophil
synthes
homonucleotid
analogu
nonhydrolyz
pec
bond
separ
none
one
two
three
bond
isoxazolidin
ring
compound
respect
instal
ceoecep
fragment
design
compound
addit
substanti
presenc
nucleosid
phosphon
drug
like
adefovir
tenofovir
cidofovir
sever
drug
candid
heat
nitron
excess
equiv
allylphosphon
c
h
result
format
even
trace
expect
product
howev
cycloaddit
nitron
alken
success
carri
microwav
irradi
scheme
progress
reaction
monitor
h
nmr
spectroscopi
disappear
start
nitron
ratio
diastereoisomer
cycloadduct
calcul
respect
p
nmr
spectra
crude
reaction
mixtur
cycloaddit
nitron
alkenylphosphon
scheme
tabl
regiospecif
gave
ci
tran
mixtur
diastereoisomer
cycloadduct
diastereoselect
de
tabl
compar
found
analog
reaction
allyl
alcohol
de
tabl
case
chromatograph
remov
unreact
alkenylphosphon
difficult
less
effect
distillingoff
excess
allyl
alcohol
thu
led
lower
overal
yield
gener
longer
reaction
time
requir
achiev
full
convers
nitron
less
reactiv
dipolarophil
compar
tabl
b
allyl
alcohol
mw
c
see
tabl
analog
reaction
allyl
alcohol
moreov
reaction
adeninederiv
nitron
allylphosphon
decomposit
start
nitron
observ
unreact
dipolarophil
recov
almost
quantit
nitron
treat
vinyloxymethylphosphon
format
complex
reaction
mixtur
notic
expect
pure
isoxazolidin
cycloadduct
could
isol
hand
trace
found
crude
reaction
mixtur
nitron
treat
alkenylphosphon
mw
irradi
verifi
stabil
nitron
condit
cycloaddit
reaction
solut
acetonitril
heat
mw
irradi
progress
reaction
monitor
h
nmr
spectroscopi
inde
format
observ
h
increas
addit
h
amount
reach
h
solut
contamin
unidentifi
decomposit
product
similarli
slow
decomposit
adeninederiv
nitron
mw
irradi
solut
acetonitril
observ
h
nmr
spectra
taken
h
reveal
decomposit
nitron
ca
sinc
addit
signal
appear
region
characterist
adenin
proton
rel
configur
well
deduc
take
account
almost
ident
h
nmr
spectral
pattern
compar
could
predict
spatial
stereoelectron
influenc
substitu
ch
ebas
ch
eoh
ch
ep
ch
eoch
p
indistinguish
impact
prefer
conform
isoxazolidin
ring
ci
tran
isom
although
unabl
unequivoc
establish
conform
addit
noe
spectral
data
support
configur
assign
come
comparison
chemic
shift
proton
ci
tran
diastereoisom
fig
thu
h
nmr
spectra
transconfigur
isoxazolidin
reson
significantli
shift
upfield
comparison
ci
isom
eg
ppm
vs
ppm
proton
tran
isom
posit
shield
cone
heteroaromat
ring
phenomenon
observ
proton
ci
tran
isoxazolidin
shield
effect
much
better
pronounc
ci
isom
eg
ppm
vs
ppm
tabl
ppm
vs
ppm
although
h
c
nmr
spectra
isoxazolidin
prepar
vinyloxymethylphosphon
resembl
regardless
nucleobas
present
significantli
differ
alreadi
discuss
tran
hand
diethyl
vinylphosphon
appli
addit
major
isoxazolidin
scheme
tabl
format
minut
amount
less
regioisomer
product
also
notic
presenc
crude
product
well
fraction
obtain
column
chromatographi
detect
p
nmr
spectroscopi
tabl
addit
prove
care
analys
h
nmr
spectra
diagnost
signal
nucleobas
proton
could
assign
four
differ
cycloadduct
name
observ
previous
h
nmr
spectra
major
minor
deriv
also
similar
within
seri
ae
noe
spectrum
interact
h
cb
well
proton
notic
thu
prove
locat
side
iso
c
nmr
spectra
one
conclud
isoxazolidin
ring
adopt
e
conform
fig
establish
tran
configur
worth
note
meaning
upfield
shift
ppm
proton
isom
ppm
comparison
ppm
noe
correl
peak
h
cb
detect
well
h
cb
medium
intens
h
cb
weak
furthermor
prefer
conform
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopath
virus
none
test
compound
show
appreci
antivir
activ
toward
test
dna
rna
virus
concentr
mm
cytostat
concentr
ic
caus
inhibit
cell
prolifer
determin
murin
leukemia
human
cd
tlymphocyt
cem
human
cervix
carcinoma
hela
human
dermal
microvascular
endotheli
cell
among
compound
evalu
margin
cytostat
activ
observ
compound
contain
adenin
uracil
thymin
substitu
nucleobas
found
inact
also
analogu
bear
moieti
show
signific
antiprolif
activ
find
indic
compound
effici
takenup
intact
tumor
cell
andor
enzymat
releas
free
andor
inhibit
thymidyl
synthas
one
import
target
enzym
new
nucleobasederiv
nitron
effici
appli
synthesi
isoxazolidin
analogu
homonucleosid
homonucleotid
reli
cycloaddit
first
allyl
alcohol
next
allyl
allyloxymethyl
vinyloxymethyland
vinylphosphon
gener
cycloaddit
regioselect
led
format
ci
tran
mixtur
isoxazolidin
moder
good
diastereoselect
howev
cycloaddit
vinylphosphon
addit
major
isoxazolidin
also
isom
form
rel
ci
tran
configur
isoxazolidin
establish
base
detail
analysi
h
c
nmr
spectral
data
vicin
coupl
shield
effect
noe
correl
sever
isoxazolidin
exist
prefer
conform
includ
obtain
vinyloxymethylphosphon
phosphonylmethoxi
group
orient
pseudoaxi
due
anomer
effect
synthes
compound
evalu
broadspectrum
dna
rna
virus
found
inact
concentr
mm
also
compound
show
signific
cytostat
activ
murin
leukemia
human
cd
tlymphocyt
cem
human
cervix
carcinoma
hela
human
dermal
microvascular
endotheli
cell
although
test
compound
contain
biolog
relev
fragment
nucleobas
isoxazolidin
ring
phosphon
surprisingli
show
appreci
antivir
anticanc
activ
sinc
isoxazolidin
subunit
also
found
sever
structur
endow
antibacteri
antifung
activ
would
progress
along
line
soon
hope
discov
new
therapeut
applic
class
compound
h
nmr
spectra
taken
cdcl
cd
od
follow
spectromet
varian
gemini
mhz
varian
bruker
avanc
iii
mhz
tm
intern
standard
follow
adsorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
prepar
hplc
experi
perform
water
apparatu
equip
water
binari
gradient
modul
water
photodiod
array
detector
nm
mixtur
nitron
mmol
allyl
alcohol
ml
stir
c
irradi
plazmatronika
microwav
reactor
c
time
shown
tabl
volatil
remov
vacuo
crude
product
purifi
silica
gel
column
use
chloroformemeoh
vv
eluent
afford
pure
isoxazolidin
detail
see
tabl
yield
inhibit
rod
induc
cytopath
tlymphocyt
cell
cultur
determin
microtit
plate
cellsml
varieti
test
compound
concentr
thirti
min
exposur
cell
test
compound
cell
cultur
infect
pg
pgml
viru
dose
afford
full
cytopath
day
incub
absenc
test
compound
control
therefor
day
incub
c
co
control
atmospher
cytopath
microscop
record
concomitantli
ml
supernat
cell
cultur
remov
well
ml
mt
solut
ad
remain
cell
suspens
h
incub
c
ml
triton
ad
absorb
measur
use
soft
max
pro
programm
cytostat
measur
base
inhibit
murin
leukemia
human
cd
tlymphocyt
cem
human
cervix
carcinoma
hela
human
dermal
microvascular
endotheli
cell
prolifer
cell
seed
cellswel
ml
microtit
plate
medium
contain
differ
concentr
test
compound
ad
day
incub
c
cell
number
determin
coulter
counter
cytostat
concentr
calcul
cc
compound
concentr
requir
inhibit
cell
prolifer
rel
number
cell
untreat
control
altern
cytotox
test
compound
confluent
hel
vero
hela
crfk
cell
cultur
use
antivir
assay
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
